| Drug Name: | Oxolinic Acid (14698-29-4) |
|---|---|
| PubChem ID: | 4628 |
| SMILES: | CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O |
| InchiKey: | KYGZCKSPAKDVKC-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Bacterial Agents, Anti-Infective Agents, Antineoplastic Agents, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Renal Agents, Topoisomerase II Inhibitors, Topoisomerase Inhibitors |
| Molecular Weight (dalton) | : | 261.233 |
| LogP | : | 1.4483 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 77.76 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Hyperkinesis | MetaADEDB |
| Movement Disorders | MetaADEDB |
| Seizures | MetaADEDB |
| Urolithiasis | MetaADEDB |